Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Problems with stopping rules in the trials of risky therapies: the case of warfarin to prevent stroke in atrial fibrillation.

Problems with stopping rules in the trials of risky therapies: the case of warfarin to prevent stroke in atrial fibrillation. Clin Res. 1993 Oct; 41(3):482-6.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.